Chris is Head of Program Management at his second biotech start-up with broad expertise in BiopharmOperations and Quality Management. In his third decade in the Life Science industry, he cultivated a user perspective intersecting R&D, Tech Transfer, Sterile Manufacturing with both Reusable and Single-use technologies, suite Startups, Validations, and Shipping with Quality Management, including FDA Consent Decree Remediation, and Third-Party Oversight. Chris led Program and Alliance Management for international programs valued over $100M, where he led highly technical, global teams assuring the Product, Process, Quality, and Business parameters of a first-of-its-kind cell therapy Drug Product.

Chris has a keen vision to architect near term solutions while simultaneously scouting a path for long term success, leading his teams to be right-first-time and cost-effective in bringing products to market that protect health. He is a Certified Manager of Quality and Organizational Effectiveness and holds a BS in Biology from Truman State University.